Now the European Medicines Agency has given their "positive scientific opinion" on the use of fexinidazole for the treatment of acute sleeping sickness as well. That opinion is based on results from an ongoing clinical trial showing that a 10-day course of pills cures the disease in 97% of patients and should lead to approval of the drug by countries outside of the EU.
One of the big concerns is that it's not easy to diagnose. "It starts with very nonspecific symptoms" like weakness, dizziness, and weight loss, according to Dr. Olaf Valver.
[
add
]
[
|
|
...
]